← Open Payments lookup

JULIE STODDARD: Open Payments

NPI 1689362998 · SALAMANCA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$837 in 42 payments from 11 companies in 2025. Trend: 2023 $562 · 2024 $4,061 · 2025 $837

Food & beverage: $837
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$319
Sumitomo Pharma America, Inc.13$144
ABBVIE INC.3$61
Bayer Healthcare Pharmaceuticals Inc.3$59
Kowa Pharmaceuticals America, Inc.2$57
Novo Nordisk Inc2$53
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Lilly USA, LLC2$36
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
Amgen Inc.1$23

Products named: GEMTESA, FARXIGA, BREZTRI, TEZSPIRE, AIRSUPRA, Kerendia, ZORYVE, Ozempic.

Industry payments across NY — which companies pay providers there.